Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption

Gastroenterology.

Jeffery IB, Das A, O'Herlihy E, Coughlan S, Cisek K, Moore M, Bradley F, Carty T, Pradhan M, Dwibedi C, Shanahan F, O'Toole PW

doi: 10.1053/j.gastro.2019.11.301.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

β-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria

Am J Gastroenterol.

Wilson B, Rossi M, Kanno T, Parkes GC, Anderson S, Mason AJ, Irving PM, Lomer MC, Whelan K

doi: 10.14309/ajg.0000000000000641.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults

Gastroenterology.

Carrasco-Labra A, Lytvyn L, Falck-Ytter Y, Surawicz CM, Chey WD

doi: 10.1053/j.gastro.2019.06.014.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Irritable Bowel Syndrome (IBS) and Chronic Constipation Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation

Curr Med Res Opin.

Barish CF, Crozier RA, Griffin P

doi: 10.1080/03007995.

Clinical intervention using Bifidobacterium strains in celiac disease children reveals novel microbial modulators of TNF-α and short-chain fatty acids

Clin Nutr.

Primec M, Klemenak M, Di Gioia D, Aloisio I, Bozzi Cionci N, Quagliariello A, Gorenjak M, Mičetić-Turk D, Langerholc T

doi: 10.1016/j.clnu.2018.06.931.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Oral administration of a lecithin-based delivery form of boswellic acids (Casperome®) for the prevention of symptoms of irritable bowel syndrome: a randomized clinical study

Minerva Gastroenterol Dietol.

Riva A, Giacomelli L, Togni S, Franceschi F, Eggenhoffner R, Zuccarini MC, Belcaro G

doi: 10.23736/S1121-421X.

Inflammatory Bowel Disease

Comparison of the metabolomic profiles of irritable bowel syndrome patients with ulcerative colitis patients and healthy controls: new insights into pathophysiology and potential biomarkers

Aliment Pharmacol Ther.

Keshteli AH, Madsen KL, Mandal R, Boeckxstaens GE, Bercik P, De Palma G, Reed DE, Wishart D, Vanner S, Dieleman LA

doi: 10.1111/apt.15141.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies

Adv Ther.

Rodiño-Janeiro BK, Vicario M, Alonso-Cotoner C, Pascua-García R, Santos J

doi: 10.1007/s12325-018-0673-5.

Celiac DiseaseIrritable Bowel Syndrome (IBS) and Chronic ConstipationInflammatory Bowel Disease

Beyond Irritable Bowel Syndrome: The Efficacy of the Low Fodmap Diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease

Dig Dis.

Testa A, Imperatore N, Rispo A, Rea M, Tortora R, Nardone OM, Lucci L, Accarino G, Caporaso N, Castiglione F

doi: 10.1159/000489487.

Related content

Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption

β-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria

AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults

Irritable Bowel Syndrome (IBS) and Chronic Constipation Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation

Clinical intervention using Bifidobacterium strains in celiac disease children reveals novel microbial modulators of TNF-α and short-chain fatty acids

Oral administration of a lecithin-based delivery form of boswellic acids (Casperome®) for the prevention of symptoms of irritable bowel syndrome: a randomized clinical study

Comparison of the metabolomic profiles of irritable bowel syndrome patients with ulcerative colitis patients and healthy controls: new insights into pathophysiology and potential biomarkers

A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies

Beyond Irritable Bowel Syndrome: The Efficacy of the Low Fodmap Diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease